Key result
The FineHeart mobile-based home monitoring app improved quality of life overall summary scores with a nonsignificant reduction in 30-day readmissions.
Why the study?
To evaluate the feasibility and preliminary effects of a digital home monitoring intervention on patient-reported outcomes and 30-day readmissions among patients with HF in Indonesia.
Does a mobile-based digital home monitoring intervention (FineHeart) improve patient-reported quality of life (KCCQ scores) and reduce 30-day hospital readmissions compared to standard care in posthospitalization patients with heart failure in Indonesia?
Does a mobile-based digital home monitoring intervention (FineHeart) improve patient-reported quality of life (KCCQ scores) and reduce 30-day hospital readmissions compared to standard care in posthospitalization patients with heart failure in Indonesia?
In a resource-limited Indonesian setting, a mobile-based home monitoring system for postdischarge heart failure patients was feasible and associated with clinically meaningful improvements in 30-day quality of life scores and a non-significant trend toward fewer readmissions.
Answers are grounded in this paper and cite their sources.
May support KCCQ gains via mobile HF monitoring; leaves open readmission effects and requires randomized trials before adoption.
Background: The risk of rehospitalization in patients with heart failure (HF) has initiated various efforts to prevent and simultaneously improve quality of life. Self-monitoring at home is one option, and technology is increasingly being used for this purpose. Objective: This pilot study aimed to evaluate the feasibility and preliminary effects of a digital home monitoring intervention on patient-reported outcomes and 30-day readmissions among patients with HF in Indonesia. Methods: A mixed methods pilot study was conducted, combining qualitative system development and quantitative evaluation. Patients were assigned to an intervention group (digital monitoring) or control group (standard care). Readmission rates were compared using chi-square tests and odds ratios. Changes in Kansas City Cardiomyopathy Questionnaire scores were analyzed using linear mixed-effects models. Results: A total of 60 patients were included (n=30, 50% in the intervention group; n=30, 50% in the control group). Readmission occurred in 20% (6/30) of patients in the intervention group and 43.3% (13/30) of patients in the control group (odds ratio 0.33, 95% CI 0.10-1.09; P=.10). Linear mixed-effects analysis showed greater improvement in Kansas City Cardiomyopathy Questionnaire overall summary score in the intervention group (P=.02). Improvements were observed in the physical limitation, symptom frequency, symptom burden, quality of life, and social limitation domains. During follow-up, 3.3% (1/30) of the patients in the intervention group died of non-HF-related causes, and 10% (3/30) of the patients in the control group died due to HF. Conclusions: This pilot study suggests that digital home monitoring is feasible and associated with improvements in patient-reported outcomes, with a potential signal toward reduced readmission. Larger studies are needed to confirm effectiveness.
No takes yet. Share an insight, caveat, or question.
Indriany et al. (2026) studied Heart failure (posthospitalization with ICD-10 primary diagnosis code I50) (n=60). FineHeart mobile-based digital home monitoring system vs. Standard care (usual hospital follow-up schedule with no home monitoring) was evaluated on 30-day all-cause hospital readmission (OR 0.33, 95% CI 0.10-1.09, p=0.10). The FineHeart mobile-based home monitoring app improved quality of life overall summary scores with a nonsignificant reduction in 30-day readmissions.
Synapse has enriched 10 related papers. Consider them for comparative context: